Compare · BTMD vs MO
BTMD vs MO
Side-by-side comparison of Biote Corp. (BTMD) and Altria Group Inc. (MO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTMD and MO operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- MO is the larger of the two at $120.13B, about 1299.4x BTMD ($92.5M).
- Over the past year, BTMD is down 37.8% and MO is up 22.3% - MO leads by 60.1 points.
- MO has been more active in the news (6 items in the past 4 weeks vs 5 for BTMD).
- MO has more recent analyst coverage (19 ratings vs 4 for BTMD).
- Company
- Biote Corp.
- Altria Group Inc.
- Price
- $2.45+0.82%
- $71.92+0.76%
- Market cap
- $92.5M
- $120.13B
- 1M return
- +20.39%
- +0.47%
- 1Y return
- -37.82%
- +22.28%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 5
- 6
- Recent ratings
- 4
- 19
Altria Group Inc.
Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, oral tobacco products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in transportation, power generation, real estate, and manufacturing equipment industries. The company sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
Latest BTMD
- SEC Form 4 filed by Director Christensen Bret
- SEC Form 4 filed by Executive Chairman Beer Marc D
- Biote Corp. filed SEC Form 8-K: Leadership Update
- Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer
- Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO
- SEC Form 8-K filed by Biote Corp.
- SEC Form 4 filed by Director Heyer Andrew R
- Director Morris Debra L converted options into 21,407 shares, increasing direct ownership by 43% to 71,562 units (SEC Form 4)
- SEC Form 4 filed by Director Cone Stephen Mark
- SEC Form 4 filed by Director Jacoby Dana Lynn
Latest MO
- SEC Form 11-K filed by Altria Group Inc.
- SEC Form 11-K filed by Altria Group Inc.
- Director Kelly Ennis Debra J sold $418,318 worth of shares (5,790 units at $72.25), decreasing direct ownership by 7% to 73,809 units (SEC Form 4)
- Director Strahlman Ellen R sold $145,118 worth of shares (2,000 units at $72.56), decreasing direct ownership by 7% to 25,102 units (SEC Form 4)
- SEC Form SD filed by Altria Group Inc.
- Amendment: SEC Form 10-K/A filed by Altria Group Inc.
- U.S. Smokeless Tobacco Company Announces Plan to Modernize Manufacturing Footprint Through Facility Relocation
- Altria Group Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Strahlman Ellen R was granted 2,571 shares, increasing direct ownership by 10% to 27,102 units (SEC Form 4)
- Director Stoddart Richard S was granted 2,571 shares, increasing direct ownership by 75% to 6,010 units (SEC Form 4)